# Mallinckrodt completes expansion of StrataGraft manufacturing facility in Madison, Wisconsin

Mallinckrodt celebrated the completion of its expanded operations and manufacturing facility for StrataGraft regenerative skin tissue in Madison, Wisconsin. The 35,000-square-foot facility provides capacity for clinical trials and commercial availability.

- Type: Expansion
- Announced: 2019-04-24
- Where: Madison, Wisconsin, United States
- Starts operating: 24 Apr 2019
- Status: completed
- Capacity: 35,000 square feet
- Products: StrataGraft regenerative skin tissue
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Mallinckrodt plc](https://endata.com/companies/29248.md)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/mallinckrodt-completes-expansion-of-operations-and-manufacturing-facility-for-stratagraft-regenerative-skin-tissue-in-madison-wis-300837826.html), 2019-04-24: "The 35,000-square-foot facility provides the necessary capacity to develop and manufacture StrataGraft regenerative skin tissue for both clinical trials and commercial availability, if approved by the FDA."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.